Пазопаниба гидрохлорид - analogs
Components: Pazopanib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: — Instructions Пазопаниба гидрохлорид | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Herba Motherwort ✘ (incl) Telaprevir ✘ (incl) Bacteriophagum Proteicum liquidum ✘ (incl) Apo-Bromocriptine ✘ (incl) Лекра-Сэт Цветки бессмертника песчаного ✘ (incl) Биоактивный экстракт из мелкой морской рыбы с хондроитином ✘ (incl) Dalfaz retard ✘ (incl) Iron plus Lady s formula ✘ (incl) Bidentis tripartitae herba ✘ (incl) Dexpanthenol-Hemofarm ✘ (incl) Bromhexine-Akrihin ✘ (incl) Butamirate ✘ (incl) Amlopress ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Negative 🔍 Pazopanib-TL | 625€ |
| ≈100% | Negative 🔍 Votrient | 799.9-937.9€ |
| ≈100% | Negative 🔍 Pazopanib | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 66% 48.5-338.1€ Sutent neutral [Sunitinib]
- 66% 585.3-1074.2€ Сунитиниб-промомед neutral [Sunitinib]
- 66% — Сунитиниб-АМЕДАРТ neutral [Sunitinib]
- 66% — Sunitinib neutral [Sunitinib]
- 66% 48€ Sunitinib-nativ neutral [Sunitinib]
- 64% — Валеотиниб neutral [Sunitinib]
- 60% 407-483.6€ Nexavar neutral [Sorafenib]
- 57% 230€ Сорафениб-натив neutral [Sorafenib]
- 57% — Флутриксан neutral [Sorafenib]
- 57% — Сорафениб-промомед neutral [Sorafenib]
- 57% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 57% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 57% — Сорафениба тозилат neutral [Sorafenib]
- 55% 1590€ Yondelis neutral [Trabectedin]
- 55% 499.5-1010€ Lenvima No 🔍 [Lenvatinib]
- 54% 970-975.6€ Inlyta neutral [Axitinib]
- 54% — Акситиниб-промомед neutral [Axitinib]
- 54% — Акситиниб-химрар neutral [Axitinib]
- 54% — Акситиниб neutral [Axitinib]
- 54% 2020-3884.5€ Кабометикс Negative 🔍 [Cabozantinib]
- 52% — Сунитиниб-химрар neutral [Sunitinib]
- 50% — Сунилиф neutral [Sunitinib]
- 50% — Серкотен neutral [Sunitinib]
- 50% — Сунитиниб Канон neutral [Sunitinib]
- 50% — Сунитиниба малат neutral [Sunitinib]
- 50% — Сунитиниб-Фарм-Синтез neutral [Sunitinib]
- 45% — Эрибулин Фармасинтез neutral [Eribulin]
- 45% — Эрибол neutral [Eribulin]
- 45% 296€ Halaven neutral [Eribulin]
- 45% — Эриксаленсе neutral [Eribulin]
- 45% — Эрибулин-промомед neutral [Eribulin]
- 45% — Eribulin neutral [Eribulin]
- 44% — Арсавио neutral [Axitinib]
- 44% — Ксинтабика neutral [Axitinib]
- 44% — Акситиниб-АМЕДАРТ neutral [Axitinib]
- 44% 230€ Sorafenib neutral [Sorafenib]
- 42% — Ибрутиниб-АМЕДАРТ neutral [Ibrutinib]
- 42% — Verzenio neutral [Abemaciclib]
- 42% — Брафтови neutral [Encorafenib]
- 42% — Ибрутиниб-Промомед neutral [Ibrutinib]
- 42% — Арбрувия neutral [Ibrutinib]
- 42% — Абемациклиб-Промомед neutral [Abemaciclib]
- 42% — Ибрутиниб Фармасинтез neutral [Ibrutinib]
- 42% — Абемациклиб neutral [Abemaciclib]
- 40% — Осимертиниб neutral [Osimertinib]
- 40% — Амекарб Negative 🔍 [Cabozantinib]
- 40% — Кабозантиниб Negative 🔍 [Cabozantinib]
- 40% — Рекобази Negative 🔍 [Cabozantinib]
- 40% — Кабозантиниб Дж Negative 🔍 [Cabozantinib]
- 40% 2538.7€ Alecensa No 🔍 [Alectinib]
Learn more about the selection of analogues
▶
- The drug has «Пазопаниба гидрохлорид» 6 full analogs, the cheapest - Пазопаниб-Фарм-Синтез (625€); 51 analog by action, the most similar - Sutent (48.5-338.1€).
- Medical online service has selected the best substitutes for Пазопаниба гидрохлорид based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Пазопаниба гидрохлорид to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.